MNC Drug Makers Say Pakistan Policies Discourage Branded-Drug Entry
This article was originally published in PharmAsia News
Executive Summary
A drug-maker group in Pakistan blamed local challenges to intellectual property rights for the failure of many international branded drugs to reach the nation’s market.